Update: 20.06.2023
Last week: 23 week 2023 (05.06.2023 - 11.06.2023)
Last full month: May 2023
| Time period | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE BERLIN-CHEMIE | |||||||||
| WoW | 67 484 | 0.6% | 2.8% | 0 | 16 417 558 | -0.3% | 3.0% | -0.1 | 1.5% |
| MoM | 314 266 | -7.9% | 2.7% | 0.1 | 78 260 736 | -9.2% | 3.0% | 0.1 | -11.7% |
| YTD | 2 108 452 | -63.5% | 2.7% | -3.3 | 549 699 724 | -51.9% | 3.2% | -2.5 | -19.3% |
| MAT | 6 173 538 | -59.6% | 3.3% | -3.5 | 1 426 881 190 | -49.2% | 3.5% | -2.7 | -16.9% |
| DEXALGIN | |||||||||
| WoW | 18 747 | 12.6% | 0.4% | 0 | 9 390 657 | 13.4% | 1.2% | 0.1 | 3.2% |
| MoM | 70 403 | -4.2% | 0.4% | 0 | 35 705 181 | -5.7% | 1.1% | 0 | -6.4% |
| YTD | 390 137 | -60.6% | 0.4% | -0.4 | 204 303 609 | -49.9% | 1.1% | -1 | -11.2% |
| MAT | 986 086 | -53.3% | 0.4% | -0.4 | 482 988 633 | -42.3% | 1.2% | -0.8 | -10.9% |
| ESPUMISAN (ADULTS) | |||||||||
| WoW | 56 382 | 2.9% | 38.5% | -1.6 | 33 093 177 | 2.2% | 44.7% | -2.7 | 7.3% |
| MoM | 234 994 | -8.3% | 39.9% | -0.8 | 139 083 566 | -10.3% | 47.2% | -1 | -6.5% |
| YTD | 1 261 303 | -50.0% | 39.9% | -19.4 | 779 105 560 | -38.6% | 48.6% | -16 | -25.7% |
| MAT | 3 023 789 | -45.6% | 43.5% | -18.7 | 1 718 617 684 | -36.3% | 50.8% | -16.7 | -22.2% |
| ESPUMISAN BABY | |||||||||
| WoW | 20 681 | 0.7% | 31.4% | -1.2 | 15 211 252 | 0.3% | 46.0% | -1.8 | 4.5% |
| MoM | 88 210 | -3.1% | 31.2% | 0.8 | 64 888 584 | -4.4% | 46.3% | 0.4 | -5.6% |
| YTD | 475 562 | -36.0% | 30.2% | -9.6 | 361 591 090 | -20.7% | 46.3% | -6.8 | -15.7% |
| MAT | 1 158 408 | -29.8% | 32.7% | -7.8 | 811 172 726 | -18.2% | 47.3% | -6.9 | -13.2% |
| FASTUM | |||||||||
| WoW | 14 625 | -8.4% | 0.8% | -0.1 | 8 760 499 | -9.5% | 2.1% | -0.3 | 2.5% |
| MoM | 63 863 | -2.5% | 0.8% | 0 | 38 550 590 | -3.7% | 2.1% | 0 | -1.8% |
| YTD | 338 972 | -40.7% | 0.9% | -0.5 | 206 002 745 | -28.5% | 2.3% | -0.5 | -8.1% |
| MAT | 807 523 | -38.3% | 0.9% | -0.5 | 464 175 018 | -26.5% | 2.3% | -0.6 | -5.7% |
| IODOMARIN | |||||||||
| WoW | 64 630 | 0.9% | 22.7% | -0.5 | 11 637 253 | 0.9% | 9.0% | -0.4 | 3.1% |
| MoM | 278 114 | -12.9% | 22.8% | -0.7 | 50 418 337 | -13.4% | 9.3% | -0.4 | -10.4% |
| YTD | 1 561 088 | 11.9% | 22.7% | 4.5 | 287 254 177 | 2.0% | 9.2% | 0.9 | -10.2% |
| MAT | 3 458 821 | 3.6% | 22.7% | 2.2 | 645 607 692 | 0.2% | 9.5% | 0.2 | -6.4% |
| LIOTON | |||||||||
| WoW | 23 548 | 18.4% | 2.1% | 0.3 | 28 546 433 | 15.4% | 4.7% | 0.5 | 4.0% |
| MoM | 87 753 | 2.4% | 1.9% | 0.1 | 111 552 357 | 2.7% | 4.5% | 0.1 | -1.9% |
| YTD | 408 836 | -41.4% | 1.7% | -0.8 | 514 282 742 | -26.7% | 4.4% | -0.6 | -15.8% |
| MAT | 962 833 | -41.9% | 1.8% | -0.9 | 1 120 549 390 | -26.4% | 4.3% | -1.2 | -14.4% |
| MEZYM | |||||||||
| WoW | 204 822 | 6.2% | 17.9% | -0.2 | 32 869 035 | 7.1% | 12.4% | 0.2 | 7.5% |
| MoM | 872 278 | -9.5% | 17.5% | -0.3 | 137 817 081 | -8.4% | 12.2% | 0 | -7.7% |
| YTD | 4 888 743 | -53.5% | 18.5% | -11.5 | 769 328 322 | -52.2% | 12.7% | -8.9 | -24.7% |
| MAT | 11 724 594 | -49.6% | 19.7% | -11.1 | 1 805 264 056 | -46.7% | 13.7% | -8.8 | -21.1% |
| MIG 400 | |||||||||
| WoW | 120 750 | 2.3% | 2.7% | 0 | 16 735 834 | 3.2% | 2.1% | 0 | 3.2% |
| MoM | 527 573 | -10.5% | 2.6% | -0.1 | 70 395 910 | -5.3% | 2.1% | 0 | -6.4% |
| YTD | 2 711 245 | -37.3% | 2.5% | -1 | 341 616 160 | -32.6% | 1.9% | -0.8 | -11.2% |
| MAT | 6 784 385 | -36.0% | 2.7% | -1.1 | 829 265 277 | -31.4% | 2.1% | -0.9 | -10.9% |
| PROSTAMOL | |||||||||
| WoW | 20 899 | 14.3% | 14.0% | 1.3 | 31 507 796 | 17.9% | 15.4% | 1.9 | 3.5% |
| MoM | 84 284 | -5.7% | 13.2% | 0.7 | 123 239 043 | -5.7% | 14.1% | 0.5 | -10.3% |
| YTD | 471 843 | -47.0% | 13.1% | -8.1 | 702 098 592 | -43.9% | 14.4% | -8.1 | -14.2% |
| MAT | 1 128 843 | -45.9% | 14.3% | -8.9 | 1 615 109 655 | -41.9% | 15.3% | -9.3 | -12.2% |
| RESPERO MYRTOL | |||||||||
| WoW | 17 456 | 8.7% | 7.8% | 0.9 | 9 065 086 | 7.4% | 7.6% | 0.8 | -3.9% |
| MoM | 74 512 | -16.4% | 6.6% | -0.2 | 39 266 715 | -17.3% | 6.6% | -0.5 | -13.9% |
| YTD | 485 553 | -28.4% | 6.9% | -2 | 268 617 260 | -14.9% | 7.6% | -1.1 | -8.1% |
| MAT | 1 108 578 | -9.5% | 7.4% | -0.3 | 576 573 803 | 2.4% | 7.9% | 0.3 | -5.2% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE B-CH | 2 108 452 | -63.5% | 2.7% | -3.3 | 549 699 724 | -51.9% | 3.2% | -2.5 | -19.3% |
| DEXALGIN | 390 137 | -60.6% | 0.4% | -0.4 | 204 303 609 | -49.9% | 1.1% | -1 | -11.2% |
| ESPUMISAN (ADULTS) | 1 261 303 | -50.0% | 39.9% | -19.4 | 779 105 560 | -38.6% | 48.6% | -16 | -25.7% |
| ESPUMISAN BABY | 475 562 | -36.0% | 30.2% | -9.6 | 361 591 090 | -20.7% | 46.3% | -6.8 | -15.7% |
| FASTUM | 338 972 | -40.7% | 0.9% | -0.5 | 206 002 745 | -28.5% | 2.3% | -0.5 | -8.1% |
| IODOMARIN | 1 561 088 | 11.9% | 22.7% | 4.5 | 287 254 177 | 2.0% | 9.2% | 0.9 | -10.2% |
| LIOTON | 408 836 | -41.4% | 1.7% | -0.8 | 514 282 742 | -26.7% | 4.4% | -0.6 | -15.8% |
| MEZYM | 4 888 743 | -53.5% | 18.5% | -11.5 | 769 328 322 | -52.2% | 12.7% | -8.9 | -24.7% |
| MIG | 2 711 245 | -37.3% | 2.5% | -1 | 341 616 160 | -32.6% | 1.9% | -0.8 | -11.2% |
| PROSTAMOL | 471 843 | -47.0% | 13.1% | -8.1 | 702 098 592 | -43.9% | 14.4% | -8.1 | -14.2% |
| RESPERO MYRTOL | 485 553 | -28.4% | 6.9% | -2 | 268 617 260 | -14.9% | 7.6% | -1.1 | -8.1% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE B-CH | 6 173 538 | -59.6% | 3.3% | -3.5 | 1 426 881 190 | -49.2% | 3.5% | -2.7 | -16.9% |
| DEXALGIN | 986 086 | -53.3% | 0.4% | -0.4 | 482 988 633 | -42.3% | 1.2% | -0.8 | -10.9% |
| ESPUMISAN (ADULTS) | 3 023 789 | -45.6% | 43.5% | -18.7 | 1 718 617 684 | -36.3% | 50.8% | -16.7 | -22.2% |
| ESPUMISAN BABY | 1 158 408 | -29.8% | 32.7% | -7.8 | 811 172 726 | -18.2% | 47.3% | -6.9 | -13.2% |
| FASTUM | 807 523 | -38.3% | 0.9% | -0.5 | 464 175 018 | -26.5% | 2.3% | -0.6 | -5.7% |
| IODOMARIN | 3 458 821 | 3.6% | 22.7% | 2.2 | 645 607 692 | 0.2% | 9.5% | 0.2 | -6.4% |
| LIOTON | 962 833 | -41.9% | 1.8% | -0.9 | 1 120 549 390 | -26.4% | 4.3% | -1.2 | -14.4% |
| MEZYM | 11 724 594 | -49.6% | 19.7% | -11.1 | 1 805 264 056 | -46.7% | 13.7% | -8.8 | -21.1% |
| MIG | 6 784 385 | -36.0% | 2.7% | -1.1 | 829 265 277 | -31.4% | 2.1% | -0.9 | -10.9% |
| PROSTAMOL | 1 128 843 | -45.9% | 14.3% | -8.9 | 1 615 109 655 | -41.9% | 15.3% | -9.3 | -12.2% |
| RESPERO MYRTOL | 1 108 578 | -9.5% | 7.4% | -0.3 | 576 573 803 | 2.4% | 7.9% | 0.3 | -5.2% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE B-CH | 67 484 | 0.6% | 2.8% | 0 | 16 417 558 | -0.3% | 3.0% | -0.1 | 1.5% |
| DEXALGIN | 18 747 | 12.6% | 0.4% | 0 | 9 390 657 | 13.4% | 1.2% | 0.1 | 3.2% |
| ESPUMISAN (ADULTS) | 56 382 | 2.9% | 38.5% | -1.6 | 33 093 177 | 2.2% | 44.7% | -2.7 | 7.3% |
| ESPUMISAN BABY | 20 681 | 0.7% | 31.4% | -1.2 | 15 211 252 | 0.3% | 46.0% | -1.8 | 4.5% |
| FASTUM | 14 625 | -8.4% | 0.8% | -0.1 | 8 760 499 | -9.5% | 2.1% | -0.3 | 2.5% |
| IODOMARIN | 64 630 | 0.9% | 22.7% | -0.5 | 11 637 253 | 0.9% | 9.0% | -0.4 | 3.1% |
| LIOTON | 23 548 | 18.4% | 2.1% | 0.3 | 28 546 433 | 15.4% | 4.7% | 0.5 | 4.0% |
| MEZYM | 204 822 | 6.2% | 17.9% | -0.2 | 32 869 035 | 7.1% | 12.4% | 0.2 | 7.5% |
| MIG | 120 750 | 2.3% | 2.7% | 0 | 16 735 834 | 3.2% | 2.1% | 0 | 3.2% |
| PROSTAMOL | 20 899 | 14.3% | 14.0% | 1.3 | 31 507 796 | 17.9% | 15.4% | 1.9 | 3.5% |
| RESPERO MYRTOL | 17 456 | 8.7% | 7.8% | 0.9 | 9 065 086 | 7.4% | 7.6% | 0.8 | -3.9% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE B-CH | 314 266 | -7.9% | 2.7% | 0.1 | 78 260 736 | -9.2% | 3.0% | 0.1 | -11.7% |
| DEXALGIN | 70 403 | -4.2% | 0.4% | 0 | 35 705 181 | -5.7% | 1.1% | 0 | -6.4% |
| ESPUMISAN (ADULTS) | 234 994 | -8.3% | 39.9% | -0.8 | 139 083 566 | -10.3% | 47.2% | -1 | -6.5% |
| ESPUMISAN BABY | 88 210 | -3.1% | 31.2% | 0.8 | 64 888 584 | -4.4% | 46.3% | 0.4 | -5.6% |
| FASTUM | 63 863 | -2.5% | 0.8% | 0 | 38 550 590 | -3.7% | 2.1% | 0 | -1.8% |
| IODOMARIN | 278 114 | -12.9% | 22.8% | -0.7 | 50 418 337 | -13.4% | 9.3% | -0.4 | -10.4% |
| LIOTON | 87 753 | 2.4% | 1.9% | 0.1 | 111 552 357 | 2.7% | 4.5% | 0.1 | -1.9% |
| MEZYM | 872 278 | -9.5% | 17.5% | -0.3 | 137 817 081 | -8.4% | 12.2% | 0 | -7.7% |
| MIG | 527 573 | -10.5% | 2.6% | -0.1 | 70 395 910 | -5.3% | 2.1% | 0 | -6.4% |
| PROSTAMOL | 84 284 | -5.7% | 13.2% | 0.7 | 123 239 043 | -5.7% | 14.1% | 0.5 | -10.3% |
| RESPERO MYRTOL | 74 512 | -16.4% | 6.6% | -0.2 | 39 266 715 | -17.3% | 6.6% | -0.5 | -13.9% |
ОБОЗНАЧЕНИЯ
WoW - Week Over Week - показатели для сравнения результатов текущей и предыдущей недели
MoM - Month Over Month - показатели для сравнения результатов последнего полного месяца и предыдущего полного месяца
YTD - Year to Date - показатели для сравнения результатов за период времени, начинающийся с первого дня текущего календарного года до текущей даты с результатами за сопоставимый период прошлого года
MAT - Moving Annual Total - показатели для сравнения результатов за период 12 месяцев, с датой окончания на последней доступной неделе, с результатами за сопоставимый период прошлого года
MS - Market Share - Доля рынка = (Продажи бренда / Продажи категории)*100%
Change, % = (Продажи бренда за последний период / Продажи бренда за предыдущий период - 1)*100%
Change, p.p. = Доля бренда на рынке за последний период - Доля бренда на рынке за предыдущий период (выражается в процентных пунктах)
Cat. Volume Change, % = (Продажи категории в упаковках за последний период / Продажи категории в упаковках за предыдущий период - 1)*100%
Каждая категория собрана специально для каждого бренда и включает в себя бренд и его конкурентов
Список конкурентов можно найти в разделе "MS of competitors" в блоке каждого бренда
ABBREVIATIONS
WoW - Week Over Week - indicators for comparing the results of the current and previous week
MoM - Month Over Month - indicators for comparing the results of the* last full month* and previous full month
YTD - Year to Date - indicators for comparing the results of the period of time beginning the first day of the current calendar year up to the current date with the results of the comparable period last year
MAT - Moving Annual Total - indicators for comparing the results of the period, being 12 month period ending on the last week with the results of the comparable period last year
MS - Market Share - (Brand Sales / Category Sales)*100%
Change, % = (Brand Sales of the last period / Brand Sales of the previous period - 1)*100%
Change, p.p. = Brand Market Share of the last period - Brand Market Share of the previous period (expressed in percentage points)
Cat. Volume Change, % = (Category Sales in packs of the last period / Category Sales in packs of the previous period - 1)*100%
Each category is created specifically for each brand and includes the brand and its competitors
The list of competitors can be found in the subsection "MS of competitors" in sections for each brand
## [1] "BROMHEXINE B-CH"## [1] "BROMHEXINE B-CH COATED TABLETS 8 MG #25"## [1] "BROMHEXINE B-CH SOL ORAL 4 MG/5 ML 60 ML #1"## [1] "ESPUMISAN (ADULTS)"## [1] "ESPUMISAN (ADULTS) CAPS 40 MG #25"## [1] "ESPUMISAN (ADULTS) CAPS 40 MG #50"## [1] "ESPUMISAN (ADULTS) EXTRA GRAN 125 MG #14"## [1] "ESPUMISAN (ADULTS) L EMULS ORAL 40 MG 30 ML #1"## [1] "ESPUMISAN BABY"## [1] "ESPUMISAN BABY ORAL DROPS 100 MG/ML 30 ML #1"## [1] "ESPUMISAN BABY ORAL DROPS 100 MG/ML 50 ML #1"## [1] "FASTUM"## [1] "FASTUM GEL FOR EXT USE 2,5% 100 G #1"## [1] "FASTUM GEL FOR EXT USE 2,5% 30 G #1"## [1] "FASTUM GEL FOR EXT USE 2,5% 50 G #1"## [1] "LIOTON"## [1] "LIOTON 1000 GEL FOR EXT USE 1000 IU/G 100 G #1"## [1] "LIOTON 1000 GEL FOR EXT USE 1000 IU/G 30 G #1"## [1] "LIOTON 1000 GEL FOR EXT USE 1000 IU/G 50 G #1"## [1] "MEZYM"## [1] "MEZYM 20000 INTESTINAL-SOLUBLE COATED TABLETS 20000 IU #20"## [1] "MEZYM FORTE COATED TABLETS #20"## [1] "MEZYM FORTE COATED TABLETS #80"## [1] "MEZYM NEO 10000 CAPS ENTEROSOLUB 10000 IU #20"## [1] "MEZYM NEO 10000 CAPS ENTEROSOLUB 10000 IU #50"## [1] "MEZYM NEO 25000 CAPS ENTEROSOLUB 25000 IU #20"## [1] "MEZYM NEO 25000 CAPS ENTEROSOLUB 25000 IU #50"## [1] "MEZYM PRO INTESTINAL-SOLUBLE COATED TABLETS 10000 ED #20"## [1] "DEXALGIN"## [1] "DEXALGIN 25 COATED TABLETS 25 MG #10"## [1] "MIG"## [1] "MIG 400 COATED TABLETS 400 MG #10"## [1] "MIG 400 COATED TABLETS 400 MG #20"## [1] "PROSTAMOL"## [1] "PROSTAMOL UNO CAPS 320 MG #30"## [1] "PROSTAMOL UNO CAPS 320 MG #60"## [1] "PROSTAMOL UNO CAPS 320 MG #90"## [1] "IODOMARIN"## [1] "IODOMARIN 100 TABS 100 MCG #100"## [1] "IODOMARIN 200 TABS 200 MCG #100"## [1] "IODOMARIN 200 TABS 200 MCG #50"## [1] "IODOMARIN FOR THE FUTURE MOTHER TABLETS 140 MG #30"## [1] "RESPERO MYRTOL"## [1] "RESPERO MYRTOL CAPS ENTEROSOLUB 120 MG #20"## [1] "RESPERO MYRTOL FORTE CAPS ENTEROSOLUB 300 MG #20"[RUS] ОБОЗНАЧЕНИЯ
WoW - Week Over Week - показатели для сравнения результатов текущей и предыдущей недели
MoM - Month Over Month - показатели для сравнения результатов последнего полного месяца и предыдущего полного месяца
YTD - Year to Date - показатели для сравнения результатов за период времени, начинающийся с первого дня текущего календарного года до текущей даты с результатами за сопоставимый период прошлого года
MAT - Moving Annual Total - показатели для сравнения результатов за период 12 месяцев, с датой окончания на последней доступной неделе, с результатами за сопоставимый период прошлого года
MS - Market Share - Доля рынка = (Продажи бренда / Продажи категории)*100%
Change, % = (Продажи бренда за последний период / Продажи бренда за предыдущий период - 1)*100%
Change, p.p. = Доля бренда на рынке за последний период - Доля бренда на рынке за предыдущий период (выражается в процентных пунктах)
Cat. Volume Change, % = (Продажи категории в упаковках за последний период / Продажи категории в упаковках за предыдущий период - 1)*100%
Каждая категория собрана специально для каждого бренда и включает в себя бренд и его конкурентов
Список конкурентов можно найти в разделе "MS of competitors" в блоке каждого бренда
[ENG] ABBREVIATIONS
WoW - Week Over Week - indicators for comparing the results of the current and previous week
MoM - Month Over Month - indicators for comparing the results of the last full month and previous full month
YTD - Year to Date - indicators for comparing the results of the period of time beginning the first day of the current calendar year up to the current date with the results of the comparable period last year
MAT - Moving Annual Total - indicators for comparing the results of the period, being 12 month period ending on the last week with the results of the comparable period last year
MS - Market Share - (Brand Sales / Category Sales)*100%
Change, % = (Brand Sales of the last period / Brand Sales of the previous period - 1)*100%
Change, p.p. = Brand Market Share of the last period - Brand Market Share of the previous period (expressed in percentage points)
Cat. Volume Change, % = (Category Sales in packs of the last period / Category Sales in packs of the previous period - 1)*100%
Each category is created specifically for each brand and includes the brand and its competitors
The list of competitors can be found in the subsection "MS of competitors" in sections for each brand
DATA SOURCES:
DSM: Sales
Palomars: TRPs
MI: Fact Digital Costs
MI Estimated Costs: TV costs